ABBOTT FDA Approval NDA 020347

NDA 020347

ABBOTT

FDA Drug Application

Application #020347

Documents

Letter2006-02-08
Letter2002-01-23
Label2016-04-11
Review2004-01-06

Application Sponsors

NDA 020347ABBOTT

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004

Application Products

001CAPSULE;ORALEQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1HYTRINTERAZOSIN HYDROCHLORIDE
002CAPSULE;ORALEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1HYTRINTERAZOSIN HYDROCHLORIDE
003CAPSULE;ORALEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1HYTRINTERAZOSIN HYDROCHLORIDE
004CAPSULE;ORALEQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1HYTRINTERAZOSIN HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1994-12-14STANDARD
LABELING; LabelingSUPPL2AP1996-09-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1996-08-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1998-04-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1998-08-06STANDARD
LABELING; LabelingSUPPL6AP2002-01-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2002-10-04STANDARD
LABELING; LabelingSUPPL9AP2006-02-06STANDARD

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL9Null0

CDER Filings

ABBOTT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20347
            [companyName] => ABBOTT
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYTRIN","activeIngredients":"TERAZOSIN HYDROCHLORIDE","strength":"EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"HYTRIN","activeIngredients":"TERAZOSIN HYDROCHLORIDE","strength":"EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"HYTRIN","activeIngredients":"TERAZOSIN HYDROCHLORIDE","strength":"EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"HYTRIN","activeIngredients":"TERAZOSIN HYDROCHLORIDE","strength":"EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"02\/06\/2006","submission":"SUPPL-9","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"HYTRIN","submission":"TERAZOSIN HYDROCHLORIDE","actionType":"EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"HYTRIN","submission":"TERAZOSIN HYDROCHLORIDE","actionType":"EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"HYTRIN","submission":"TERAZOSIN HYDROCHLORIDE","actionType":"EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"HYTRIN","submission":"TERAZOSIN HYDROCHLORIDE","actionType":"EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2006-02-06
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.